Skip to main content
Top
Published in: Cancer Causes & Control 10/2015

01-10-2015 | Brief report

Performance of digital screening mammography in a population-based cohort of black and white women

Authors: Louise M. Henderson, Thad Benefield, Sarah J. Nyante, Mary W. Marsh, Mikael Anne Greenwood-Hickman, Bruce F. Schroeder

Published in: Cancer Causes & Control | Issue 10/2015

Login to get access

Abstract

Purpose

There is scarce information on whether digital screening mammography performance differs between black and white women.

Methods

We examined 256,470 digital screening mammograms performed from 2005 to 2010 among 31,654 black and 133,152 white Carolina Mammography Registry participants aged ≥40 years. We compared recall rate, sensitivity, specificity, and positive predictive value (PPV1) between black and white women, adjusting for potential confounders using random effects logistic regression.

Results

Breast cancer was diagnosed in 276 black and 1,095 white women. Recall rates were similar for blacks and whites (8.6 vs. 8.5 %), as were sensitivity (83.7 vs. 82.4 %), specificity (91.8 vs. 91.9 %), and PPV1 (4.8 vs. 5.3 %) (all p values >0.05). Stratified and adjusted models showed similar results. Despite comparable mammography performance, tumors diagnosed in black women were more commonly poorly differentiated and hormone receptor negative.

Conclusion

Equivalent performance of digital screening mammography by race suggests that efforts to understand tumor disparities should focus on etiologic factors that influence tumor biology.
Literature
2.
go back to reference Gill KS, Yankaskas BC (2004) Screening mammography performance and cancer detection among black women and white women in community practice. Cancer 100(1):139–148CrossRefPubMed Gill KS, Yankaskas BC (2004) Screening mammography performance and cancer detection among black women and white women in community practice. Cancer 100(1):139–148CrossRefPubMed
3.
go back to reference Bluekens AM, Holland R, Karssenmeijer N, Broeders MJ, den Heeten GJ (2012) Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study. Radiology 265(3):707–714CrossRefPubMed Bluekens AM, Holland R, Karssenmeijer N, Broeders MJ, den Heeten GJ (2012) Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study. Radiology 265(3):707–714CrossRefPubMed
4.
go back to reference Pisano ED, Gastonis C, Hendrick E et al (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353(17):1773–1783CrossRefPubMed Pisano ED, Gastonis C, Hendrick E et al (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353(17):1773–1783CrossRefPubMed
5.
go back to reference American Cancer Society (2013) Breast cancer facts and figures 2013–2014. American Cancer Society, Inc., Atlanta American Cancer Society (2013) Breast cancer facts and figures 2013–2014. American Cancer Society, Inc., Atlanta
6.
go back to reference Habel LA, Capra AM, Oestreicher N et al (2007) Mammographic density in a multiethnic cohort. Menopause 14(5):891–899CrossRefPubMed Habel LA, Capra AM, Oestreicher N et al (2007) Mammographic density in a multiethnic cohort. Menopause 14(5):891–899CrossRefPubMed
7.
go back to reference Conroy SM, Butler LM, Harvey D et al (2010) Physical activity and change in mammographic density: the study of women’s health across the nation. Am J Epidemiol 171(9):960–968 PMID: 20354074. PMCID: PMC2877475 CrossRefPubMedCentralPubMed Conroy SM, Butler LM, Harvey D et al (2010) Physical activity and change in mammographic density: the study of women’s health across the nation. Am J Epidemiol 171(9):960–968 PMID: 20354074. PMCID: PMC2877475 CrossRefPubMedCentralPubMed
8.
go back to reference American College of Radiology (2003) The American College of Radiology breast imaging reporting and data system (BI-RADS), 4th edn. American Coll Radiology, Reston American College of Radiology (2003) The American College of Radiology breast imaging reporting and data system (BI-RADS), 4th edn. American Coll Radiology, Reston
9.
go back to reference Yankaskas BC, Taplin SH, Ichikawa L, Geller BM, Rosenberg RD, Carney PA et al (2005) Association between mammography timing and measures of screening performance in the United States. Radiology 234:363–373 [PMID: 15670994] CrossRefPubMed Yankaskas BC, Taplin SH, Ichikawa L, Geller BM, Rosenberg RD, Carney PA et al (2005) Association between mammography timing and measures of screening performance in the United States. Radiology 234:363–373 [PMID: 15670994] CrossRefPubMed
11.
go back to reference McLean RA, Sanders WL, Stroup WW (1991) A unified approach to mixed linear models. Am Stat 45:54–64 McLean RA, Sanders WL, Stroup WW (1991) A unified approach to mixed linear models. Am Stat 45:54–64
12.
go back to reference Kerlikowske K, Hubbard RA, Miglioretti DL et al (2011) Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med 155:493–502CrossRefPubMedCentralPubMed Kerlikowske K, Hubbard RA, Miglioretti DL et al (2011) Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med 155:493–502CrossRefPubMedCentralPubMed
Metadata
Title
Performance of digital screening mammography in a population-based cohort of black and white women
Authors
Louise M. Henderson
Thad Benefield
Sarah J. Nyante
Mary W. Marsh
Mikael Anne Greenwood-Hickman
Bruce F. Schroeder
Publication date
01-10-2015
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 10/2015
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0631-3

Other articles of this Issue 10/2015

Cancer Causes & Control 10/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine